Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
US Stock MarketDetailed Quotes
MoonLake Immunotherapeutics (MLTX)
- 18.250
- -0.160-0.87%
Trading May 14 13:40 ET
1.34BMarket Cap-4.70P/E (TTM)
18.665High17.860Low264.94KVolume18.500Open18.410Prev Close4.82MTurnover0.64%Turnover RatioLossP/E (Static)73.62MShares62.75052wk High5.29P/B757.86MFloat Cap5.95052wk Low--Dividend TTM41.53MShs Float64.980Historical High--Div Yield TTM4.37%Range %4.250Historical Low18.189Avg Price1Lot Size
MoonLake Immunotherapeutics (MLTX) Cash Flow
Quarterly+Annual
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -73.80%-66.29M | -68.12%-196.01M | -21.29%-58.79M | -76.23%-44.54M | -95.52%-54.53M | -155.15%-38.14M | -172.54%-116.59M | -292.68%-48.47M | -173.24%-25.28M | -129.38%-27.89M |
| Net income from continuing operations | -71.87%-69.71M | -89.96%-230.32M | -35.83%-63.02M | -95.74%-70.69M | -126.39%-56.05M | -190.23%-40.56M | -175.06%-121.24M | -488.23%-46.4M | -210.82%-36.12M | -100.42%-24.76M |
| Operating gains losses | 375.00%11K | -5,900.00%-58K | -875.00%-31K | -800.00%-18K | -1,738.24%-5K | -1,370.59%-4K | 101.18%1K | 111.68%4K | 91.65%-2K | 97.99%-272 |
| Depreciation and amortization | 123.54%845K | 88.88%2.62M | 106.32%751K | 112.25%745K | 116.96%742K | 15.24%378K | 274.32%1.39M | 1.07%364K | 10,568.69%351K | 10,298.30%342K |
| Other non cash items | 240.32%422K | -349.34%-1.02M | 80.75%-92K | -22.25%283K | -6,775.00%-1.34M | 193.23%124K | -277.34%-227K | -1,610.94%-478K | 4,999.06%364K | 224.52%20K |
| Change In working capital | -2,938.48%-11.21M | 625.32%19.88M | 100.15%6K | 158.72%21.43M | 77.65%-1.19M | 87.03%-369K | 39.14%-3.78M | 39.22%-3.9M | 752.84%8.28M | -309.53%-5.32M |
| -Change in receivables | -512.33%-894K | -13.38%-2.03M | -94.27%-847K | 16.16%-612K | -132.04%-420K | 66.74%-146K | -112.62%-1.79M | -29.62%-436K | -622.86%-730K | 25.00%-181K |
| -Change in prepaid assets | -3,799.63%-10.1M | 104.35%561K | 171.82%3.86M | -81.56%274K | 53.00%-3.84M | 132.77%273K | -103.17%-12.89M | 25.57%-5.37M | 128.58%1.49M | -824.34%-8.18M |
| -Change in payables and accrued expense | -34.80%950K | 87.85%23.15M | -206.96%-2.63M | 174.35%21.06M | -2.74%3.26M | 225.39%1.46M | 881.21%12.32M | 88.66%2.46M | 1,562.67%7.68M | 2,607.46%3.35M |
| -Change in other current assets | 54.12%-779K | -9,683.33%-587K | --0 | --1.11M | --1K | -33,860.00%-1.7M | 90.91%-6K | 98.48%-1K | --0 | --0 |
| -Change in other current liabilities | -52.55%-389K | 14.13%-1.22M | 31.58%-377K | -169.13%-401K | 40.38%-189K | 37.19%-255K | -540.99%-1.42M | -428.95%-551K | -276.62%-149K | -703.65%-317K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -73.80%-66.29M | -68.12%-196.01M | -21.29%-58.79M | -76.23%-44.54M | -95.52%-54.53M | -155.15%-38.14M | -172.54%-116.59M | -292.68%-48.47M | -173.24%-25.28M | -129.38%-27.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -99.83%98K | 198.73%202.99M | 79.70%-29.91M | 51.68%88.4M | 200.58%88.25M | 295.27%56.25M | -716.38%-205.6M | -226.07%-147.33M | 133.42%58.28M | -792.19%-87.74M |
| Net PPE purchase and sale | --0 | 93.27%-35K | --0 | --0 | --0 | 83.49%-35K | -83.10%-520K | 38.03%-176K | ---132K | --0 |
| Net investment purchase and sale | -99.83%98K | 199.00%203.03M | 79.67%-29.91M | 51.34%88.4M | 200.58%88.25M | 296.84%56.28M | -723.60%-205.08M | -225.61%-147.16M | 133.50%58.41M | -792.19%-87.74M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -99.83%98K | 198.73%202.99M | 79.70%-29.91M | 51.68%88.4M | 200.58%88.25M | 295.27%56.25M | -716.38%-205.6M | -226.07%-147.33M | 133.42%58.28M | -792.19%-87.74M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -58.09%30.64M | 184.53%146M | 47,843.71%72.4M | 162.30%480K | 0 | 43.44%73.12M | -89.30%51.31M | -99.47%151K | 183K | 0 |
| Net issuance payments of debt | -66.49%24.47M | --73.02M | --0 | --0 | --0 | --73.02M | --0 | --0 | --0 | --0 |
| Net common stock issuance | --6.01M | 37.79%72.4M | --72.4M | --0 | --0 | --0 | -89.11%52.54M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 70.00%170K | 139.67%580K | --0 | 427.47%480K | --0 | --100K | --242K | --151K | --91K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 46.60%-1.47M | --0 | --92K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -58.09%30.64M | 184.53%146M | 47,843.71%72.4M | 162.30%480K | --0 | 43.44%73.12M | -89.30%51.31M | -99.47%151K | --183K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 85.40%334.52M | -60.01%180.43M | -6.63%350.74M | -10.53%306.68M | -40.76%271.57M | -60.01%180.43M | 1,042.03%451.17M | 18.07%375.66M | -31.69%342.79M | 814.52%458.44M |
| Current changes in cash | -138.96%-35.54M | 156.48%152.98M | 91.66%-16.31M | 33.60%44.34M | 129.16%33.72M | 1,162.50%91.23M | -165.79%-270.87M | -247.18%-195.65M | 118.07%33.19M | -125.59%-115.63M |
| Effect of exchange rate changes | -448.86%-483K | 766.41%1.11M | -78.54%91K | 12.31%-285K | 8,282.35%1.39M | -291.30%-88K | 268.42%128K | 562.01%424K | -6,592.21%-325K | 88.24%-17K |
| End cash Position | 9.91%298.49M | 85.40%334.52M | 85.40%334.52M | -6.63%350.74M | -10.53%306.68M | -40.76%271.57M | -60.01%180.43M | -60.01%180.43M | 18.07%375.66M | -31.69%342.79M |
| Free cash flow | -73.64%-66.29M | -67.40%-196.04M | -20.85%-58.79M | -75.31%-44.54M | -95.52%-54.53M | -151.81%-38.18M | -171.95%-117.11M | -285.24%-48.65M | -174.66%-25.41M | -129.38%-27.89M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm